DiarioFarma. 2016 marks the 10th anniversary of the launch of the first biosimilar. A milestone that was met by Sandoz, a company that currently leads this field by having three drugs marketed and a broad development pipeline. To analyze what has happened in these ten years, the CEO of Sandoz, Joaquín Rodrigo, has given an interview to Diariofarma.